• Return to Headlines

Accelerate Diagn is Among the Companies in the Life Sciences Tools & Services Industry With the Lowest Sales per Share (AXDX, PACB, FLDM, NEO, NSTG)

By Shiri Gupta

Below are the three companies in the Life Sciences Tools & Services industry with the lowest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Accelerate Diagn ranks lowest with a sales per share of $0.08. Pacific Bioscien is next with a sales per share of $0.78. Fluidigm Corp ranks third lowest with a sales per share of $2.90.

Neogenomics Inc follows with a sales per share of $3.19, and Nanostring Techn rounds out the bottom five with a sales per share of $4.89.

SmarTrend recommended that subscribers consider buying shares of Nanostring Techn on August 10th, 2018 as our technology indicated a new Uptrend was in progress when shares hit $13.45. Since that recommendation, shares of Nanostring Techn have risen 31.5%. We continue to monitor Nanostring Techn for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: lowest sales per share accelerate diagn pacific bioscien fluidigm corp neogenomics inc nanostring techn

Ticker(s): AXDX PACB FLDM NEO NSTG